The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday newspaper round-up: BAE Systems, Mark Carney, Japan...

Thu, 20th Dec 2012 06:51

The continued haggling with Saudi Arabia over the price of 48 Eurofighter Typhoon jets could hit full-year profits at BAE Systems. The British defence contractor said that negotiations with the Royal Saudi Air Force about the price of the aircraft may not be concluded before its results announcement in February. That could wipe 3p per share off underlying earnings, the company warned in a trading update yesterday. Analysts are forecasting earnings of about 40p per share, compared with 37p in 2011. [The Times]Incoming Bank of England governor Mark Carney will pocket an annual £250,000 housing allowance, taking his total pay package close to £1m a year when he takes the reins next summer, the central bank has revealed. Carney will receive the allowance as part of a generous package put together by the chancellor, George Osborne, to lure him from his current job in Ottawa as boss of the Canadian central bank. It was already known that Carney would be paid a salary of £480,000 and pension contributions worth £144,000. He will also receive free health and dental insurance and the use of a chauffeur-driven car.[The Guardian]The Bank of Japan has stepped up its monetary easing with a Y10tn ($118bn) increase in the size of its asset-purchasing programme, and signalled that it could move to adopt a higher inflation target, as requested by Shinzo Abe, the incoming prime minister. Mr Abe welcomed the BoJ's move, saying "what we called for during the Lower House election is being realised one by one." During the election campaign, he called for the BoJ to do more to combat persistent deflation by adopting "unlimited" easing and an inflation target of 2 per cent or more. [Financial Times]The Department of Justice has charged two former UBS traders with conspiracy to manipulate Libor, on the same day the Swiss banking giant agreed to pay £940m in fines to settle charges linked to the key global interest rate. Tom Alexander William Hayes, 33-year-old British former Tokyo-based trader, and Roger Darin, a Switzerland-based managing director responsible for the bank's Libor submissions, were both charged with conspiracy, the US Justice Department said. Hayes was also charged with wire fraud and a "price-fixing violation arising from his collusive activity with another bank to manipulate Libor". Mr Hayes' official naming followed his arrest last week by the Serious Fraud Office in connection with its own investigation into Libor-rigging. Two other men, both brokers in the City, were also arrested. [The Telegraph]America's two largest mortgage lenders could have lost more than $3bn (£1.85bn) as a result of banks' alleged manipulation of Libor. Fannie Mae and Freddie Mac, the giant US mortgage lenders, have been told they should consider suing banks amid allegations that several major financial institutions rigged key borrowing rates for several years. According to reports, the two lenders are likely to have lost several billions of dollars as a direct result of interest rates being artificially increased and decreased by banks. [The Telegraph]Next year will be "a make or break" year for Greece's future as a member of the eurozone, the country's finance minister has said, warning Europe's leaders that Athens still faces "the possible risk" of crashing out of the currency bloc. "We can make it next year if we can stick to the programme agreed with the EU and IMF," Yannis Stournaras said in an interview with the Financial Times. However, "the break would be if the political system finds the situation too difficult to handle", he added, referring to the danger of social unrest about austerity that could force the two left-of-centre parties to bring down the governing coalition. [Financial Times]GlaxoSmithKline has reached a $150m (£92m) preliminary settlement with US drug wholesalers who claimed the company improperly delayed entry to the market of generic alternatives to its nasal spray Flonase, according to court documents. The settlement was reached with, among others, AmerisourceBergen, Cardinal Health and McKesson Corp, who maintained that Glaxo had abused the citizen's petition process to maintain a market monopoly. [The Independent]The soap opera continued at Bumi yesterday after yet another board member was forced to resign from the conflict-riven Indonesian coal miner created by Nat Rothschild and the Bakrie family in November 2010. In a day of action, the Takeover Panel ruled that there was improper disclosure about the close relationship between two key shareholders - the Bakrie brothers and Rosan Roeslani - when the group was created by injecting the Bakries' Indonesian coal-mining assets into Mr Rothschild's listed cash shell. The Panel ruled yesterday that the two groups had acted "in concert" - and cut the voting power of their combined 57 per cent stake almost in half, to 29.9 per cent. [The Independent]BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.